Cibus vs Evogene
CBUS and EVGN side by side, both in chemicals and allied products. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How CBUS and EVGN compare
Cibus grew revenue faster over the last twelve months (−10.3% versus −30.9% for Evogene).
Evogene keeps more of each dollar of sales as profit, with a net margin of −220% compared with −2259% at Cibus.
Cibus scores higher on the StockData Score (4 against 3 for Evogene), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | CBUS | EVGN |
|---|---|---|
| Size and price | ||
| Market cap | $88.7M | – |
| Share price | $1.16 | $0.395 |
| Change, 1 year | −12.8% | −66.6% |
| Change, 5 years | −99.3% | −98.1% |
| Beta (5Y) | 1.74 | 1.04 |
| Employees | 118 | 78 |
| StockData Score | ||
| Total score | 4 (better) | 3 |
| Valuation score | 0 | 0 |
| Growth score | 1 | 1 |
| Performance score | 1 | 1 |
| Health score | 2 (better) | 1 |
| Dividend score | 0 | 0 |
| Valuation | ||
| P/S | 20.4× | – |
| P/B | 6.0× | – |
| FCF yield | −52.2% | – |
| Fair value | $0.461 | – |
| Margin of safety | −151% | – |
| Growth | ||
| Revenue growth (TTM) | −10.3% (better) | −30.9% |
| Revenue growth, 5Y average | −31.3% | 29.9% (better) |
| Profitability | ||
| Gross margin | – | −6.3% |
| Operating margin | −1451% | −364% (better) |
| Net margin | −2259% | −220% (better) |
| FCF margin | −1066% | −354% (better) |
| Return on equity | −226% | – |
| Return on invested capital | −311% | – |
| Financial health | ||
| Debt / equity | 0.06 | – |
| Interest coverage | – | −7.3× |
| Current ratio | 1.62 | 3.57 (better) |
| Altman Z-score | −4.46 | – |
| Piotroski F-score | 4 (better) | 3 |
| Dividends and buybacks | ||
| Shareholder yield | 0.00% | – |
| Ownership | ||
| Held by institutions | 24.2% | 3.2% |
| Held by insiders | 35.2% | 50.7% |
| Insider net buying, 12 months | – | $695K |
| Short interest, % of float | 6.2% | 1.6% |
Go deeper
- CBUS stock overview
- CBUS income statement
- CBUS valuation and score
- EVGN stock overview
- EVGN income statement
- EVGN valuation and score
For information only, not investment advice. Check the source filings before relying on any figure.